Evogene Gross Profit from 2010 to 2024
| EVGN Stock | USD 0.65 0.04 6.56% |
Gross Profit | First Reported 2011-12-31 | Previous Quarter 3.3 M | Current Value -483 K | Quarterly Volatility 1.2 M |
Check Evogene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evogene main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.2 M, Interest Expense of 109.2 K or Selling General Administrative of 5.2 M, as well as many exotic indicators such as Price To Sales Ratio of 6.46, Dividend Yield of 0.0 or PTB Ratio of 2.16. Evogene financial statements analysis is a perfect complement when working with Evogene Valuation or Volatility modules.
Evogene | Gross Profit |
Latest Evogene's Gross Profit Growth Pattern
Below is the plot of the Gross Profit of Evogene over the last few years. Gross profit is a required income statement account that reflects total revenue of Evogene minus its cost of goods sold. It is profit before Evogene operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Evogene's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evogene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 766 K | 10 Years Trend |
|
Gross Profit |
| Timeline |
Evogene Gross Profit Regression Statistics
| Arithmetic Mean | 2,868,295 | |
| Geometric Mean | 1,478,188 | |
| Coefficient Of Variation | 100.94 | |
| Mean Deviation | 2,501,497 | |
| Median | 1,399,000 | |
| Standard Deviation | 2,895,379 | |
| Sample Variance | 8.4T | |
| Range | 7.4M | |
| R-Value | (0.80) | |
| Mean Square Error | 3.3T | |
| R-Squared | 0.64 | |
| Significance | 0.0004 | |
| Slope | (517,354) | |
| Total Sum of Squares | 117.4T |
Evogene Gross Profit History
Other Fundumenentals of Evogene
Evogene Gross Profit component correlations
Click cells to compare fundamentals
About Evogene Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Evogene income statement, its balance sheet, and the statement of cash flows. Evogene investors use historical funamental indicators, such as Evogene's Gross Profit, to determine how well the company is positioned to perform in the future. Although Evogene investors may use each financial statement separately, they are all related. The changes in Evogene's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evogene's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evogene Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evogene. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.4 M | 2.1 M | |
| Gross Profit Margin | 0.25 | 0.36 |
Pair Trading with Evogene
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evogene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will appreciate offsetting losses from the drop in the long position's value.Moving together with Evogene Stock
| 0.64 | EGRX | Eagle Pharmaceuticals | PairCorr |
| 0.65 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Evogene Stock
| 0.43 | ELYM | Eliem Therapeutics | PairCorr |
The ability to find closely correlated positions to Evogene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evogene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evogene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evogene to buy it.
The correlation of Evogene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evogene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evogene moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evogene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Evogene Correlation against competitors. To learn how to invest in Evogene Stock, please use our How to Invest in Evogene guide.Note that the Evogene information on this page should be used as a complementary analysis to other Evogene's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Evogene Stock analysis
When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Evogene's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evogene. If investors know Evogene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evogene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.123 | Quarterly Revenue Growth (0.12) | Return On Assets (0.31) | Return On Equity (0.82) |
The market value of Evogene is measured differently than its book value, which is the value of Evogene that is recorded on the company's balance sheet. Investors also form their own opinion of Evogene's value that differs from its market value or its book value, called intrinsic value, which is Evogene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evogene's market value can be influenced by many factors that don't directly affect Evogene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evogene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evogene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evogene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.